The relationship between brain metastasis and HER2 expression status in gastric cancer

被引:0
作者
Ming-Yu Lai
Wen-Long Guan
Jing Yang
Yu-Ting Sun
Shi-Xun Lu
Li-Qiong Yang
Da-Jun Yang
Miao-Zhen Qiu
机构
[1] Sun Yat-sen University Cancer Center,Department of Medical Oncology
[2] State Key Laboratory of Oncology in South China,Department of Pathology
[3] Collaborative Innovation Center for Cancer Medicine,Department of Experiment Research
[4] Sun Yat-Sen University Cancer Center,undefined
[5] State Key Laboratory of Oncology in South China,undefined
[6] Collaborative Innovation Center for Cancer Medicine,undefined
[7] Sun Yat-Sen University Cancer Center,undefined
[8] State Key Laboratory of Oncology in South China,undefined
[9] Collaborative Innovation Center for Cancer Medicine,undefined
来源
Clinical and Translational Oncology | 2024年 / 26卷
关键词
Gastric cancer; Human epidermal growth factor 2 amplification; Brain metastasis; SEER database;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:765 / 773
页数:8
相关论文
共 144 条
[1]  
Thrift AP(2020)Burden of gastric cancer Clin Gastroenterol Hepatol 18 534-542
[2]  
El-Serag HB(2010)Comparison in pathological behaviours & prognosis of gastric cancers from general hospitals between China & Japan Indian J Med Res 132 295-302
[3]  
Yu M(2011)Gastrointestinal cancer and brain metastasis: a rare and ominous sign Cancer 117 3630-3640
[4]  
Zheng HC(2018)Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: a SEER-based study Cancer Med 7 3662-3672
[5]  
Xia P(2008)Assessment of a HER2 scoring system for gastric cancer: results from a validation study Histopathology 52 797-805
[6]  
Takahashi H(2011)Impact of HER-2 overexpression/amplification on the prognosis of gastric cancer patients undergoing resection: a single-center study of 1,036 patients Oncologist 16 1706-1713
[7]  
Masuda S(2013)HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance Ann Oncol 24 2360-2364
[8]  
Takano Y(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697
[9]  
Go PH(2012)Brain metastases free survival differs between breast cancer subtypes Br J Cancer 106 440-446
[10]  
Klaassen Z(1965)The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol Microbiol Scand 64 31-49